Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 21, 2020 at 03:42 am EDT
Share
Jiangsu Apon Medical Technology Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 134.412 million compared to CNY 169.271 million a year ago. Operating income was CNY 41.542 million compared to CNY 48.215 million a year ago. Net income was CNY 32.839 million compared to CNY 41.212 million a year ago. Basic earnings per share from continuing operations was CNY 0.31 compared to CNY 0.39 a year ago.
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.
JIANGSU APON MEDICAL TECHNOLOGY CO., LTD. 
